Lotus Eye Hospital and Institute Limited Share Price Bombay S.E.

Equities

LOTUSEYE

INE947I01017

Healthcare Facilities & Services

Market Closed - Bombay S.E. 03:30:50 26/04/2024 pm IST 5-day change 1st Jan Change
61 INR +1.70% Intraday chart for Lotus Eye Hospital and Institute Limited +0.83% -26.81%
Sales 2022 389M 4.67M Sales 2023 470M 5.64M Capitalization 1.22B 14.62M
Net income 2022 29M 348K Net income 2023 40M 480K EV / Sales 2022 2.64 x
Net cash position 2022 75.55M 906K Net cash position 2023 76.6M 919K EV / Sales 2023 2.43 x
P/E ratio 2022
36.9 x
P/E ratio 2023
29.9 x
Employees 313
Yield 2022
0.94%
Yield 2023
0.85%
Free-Float 55.24%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.70%
1 week+0.83%
Current month+7.96%
1 month+5.06%
3 months-23.78%
6 months-23.15%
Current year-26.81%
More quotes
1 week
58.50
Extreme 58.5
62.97
1 month
56.01
Extreme 56.01
64.20
Current year
44.10
Extreme 44.1
95.00
1 year
44.10
Extreme 44.1
110.90
3 years
38.65
Extreme 38.65
110.90
5 years
16.05
Extreme 16.05
110.90
10 years
5.57
Extreme 5.57
110.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 74 31/20/31
Director of Finance/CFO 66 25/22/25
Compliance Officer - 15/22/15
Members of the board TitleAgeSince
Director/Board Member 85 16/07/16
Director/Board Member 75 16/07/16
Director/Board Member 47 01/09/01
More insiders
Date Price Change Volume
26/24/26 61 +1.70% 10,952
25/24/25 59.98 -2.63% 8,637
24/24/24 61.6 +4.07% 2,449
23/24/23 59.19 -1.19% 1,154
22/24/22 59.9 -0.99% 1,009

Delayed Quote Bombay S.E., April 26, 2024 at 03:30 pm IST

More quotes
Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company operates primarily in the field of ophthalmology (Eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides treatments through ReLEx SMILE, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates approximately seven centers at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin, and Mulanthurthy.
More about the company